These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30062588)

  • 1. Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement.
    Rossi MC; Lucisano G; Ceriello A; Mazzucchelli C; Musacchio N; Ozzello A; Nicolucci A; Di Bartolo P;
    Acta Diabetol; 2018 Oct; 55(10):1059-1066. PubMed ID: 30062588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care.
    Montero AR; Toro-Tobon D; Gann K; Nassar CM; Youssef GA; Magee MF
    BMC Endocr Disord; 2021 Nov; 21(1):222. PubMed ID: 34758807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial.
    Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG
    J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
    Del Prato S; Giorgino F; Szafranski K; Poon Y
    Diabetes Obes Metab; 2024 Sep; 26(9):3633-3641. PubMed ID: 38853717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective study.
    Kesavadev J; Shankar A; Pillai PB; Krishnan G; Jothydev S
    Diabetes Technol Ther; 2012 Sep; 14(9):772-6. PubMed ID: 22734662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.
    Kusunoki Y; Katsuno T; Nakae R; Watanabe K; Akagami T; Ochi F; Tokuda M; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2015 May; 108(2):342-9. PubMed ID: 25779865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
    Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
    J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of self-monitoring blood glucose and attainment of HbA1c target values.
    Elgart JF; González L; Prestes M; Rucci E; Gagliardino JJ
    Acta Diabetol; 2016 Feb; 53(1):57-62. PubMed ID: 25841589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HYPERGLYCEMIA AND HYPOGLYCEMIA IN PATIENTS WITH DIABETES IN SKILLED NURSING FACILITIES.
    Patell R; Nigmatoulline D; Bena J; Kim DG; Messinger-Rapport B; Lansang MC
    Endocr Pract; 2017 Apr; 23(4):458-465. PubMed ID: 28156156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes.
    Kovatchev BP; Cox DJ; Gonder-Frederick L; Clarke WL
    Diabetes Technol Ther; 2002; 4(3):295-303. PubMed ID: 12165168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.
    Scavini M; Bosi E; Ceriello A; Giorgino F; Porta M; Tiengo A; Vespasiani G; Bottalico D; Marino R; Parkin C; Bonizzoni E; Cucinotta D
    Acta Diabetol; 2013 Oct; 50(5):663-72. PubMed ID: 22189755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin.
    Bonomo K; De Salve A; Fiora E; Mularoni E; Massucco P; Poy P; Pomero A; Cavalot F; Anfossi G; Trovati M
    Diabetes Res Clin Pract; 2010 Feb; 87(2):246-51. PubMed ID: 19954855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.